PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Mar-2021 TrakCel fuels growth and increased market access through strategic investment round TrakCel
03-Mar-2021 US court decision favours Symbicort in patent litigation AstraZeneca
03-Mar-2021 AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX AstraZeneca
03-Mar-2021 Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck With Funding to Expand Merck’s Manufacturing Capacity for COVID-19 Vaccines and Medicines Merck
03-Mar-2021 IQVIA to Participate in the Barclays Global Healthcare Conference on March 09, 2021 IQVIA
03-Mar-2021 Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy Santhera
03-Mar-2021 Idorsia submits European marketing authorisation application for daridorexant for the treatment of adult patients with insomnia Idorsia Ltd
03-Mar-2021 IBA receives down payment from National Cancer Center Korea for a second Proteus® System IBA (Ion Beam Applications SA)
02-Mar-2021 MorphoSys's Licensing Partner GSK Shared Preliminary Results From OSCAR Study with Otilimab for the Treatment of Severe Pulmonary COVID-19 Related Disease MorphoSys AG
02-Mar-2021 Pharma Jobs in Germany on PharmiWeb.jobs PharmiWeb
02-Mar-2021 Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US Merck
02-Mar-2021 U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review Merck
02-Mar-2021 Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity Boehringer Ingelheim
02-Mar-2021 Further update on US regulatory review of roxadustat in anaemia of chronic kidney disease AstraZeneca
02-Mar-2021 Evonik recognized as a leading contract manufacturing organization for the pharmaceutical industry for the fourth year in a row Evonik
02-Mar-2021 Idorsia submits NDA for clazosentan to Japanese PMDA Idorsia Ltd
02-Mar-2021 Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial Santhera
02-Mar-2021 Oxular raises $37 million Oxular Limited
02-Mar-2021 Virpax(R) Pharmaceuticals Inc.: Virpax Pharmaceuticals Announces Newly Issued Patent for Probudur(TM) Virpax® Pharmaceuticals Inc.
02-Mar-2021 Kartesia completes capital increase and acquires 100% stake in ADL Biopharma; Ignacio Urbelz appointed as new CEO ADL Biopharma